Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MiMedx Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
MiMedx Group Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
MiMedx Group Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
MiMedx Group Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
MiMedx Group Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MiMedx Group Inc, Medical Equipment, Deal Details 11
Partnerships 11
MiMedx Enters Into Distribution Agreement With Medtronic And SpinalGraft Technologies 11
MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 12
Equity Offering 13
MiMedx Completes Public Offering Of Shares For US$39 Million 13
MiMedx Group Completes Private Placement Of Shares For US$5 Million Upon Exercise Of Warrants 15
MiMedx Group Completes Private Placement Of US$6.6 Million 16
Acquisition 17
MiMedx Sells its Stability Biologics 17
MiMedx Acquires Stability Biologics 18
MiMedx Completes Acquisition Of Surgical Biologics 19
MiMedx Group Inc – Key Competitors 20
MiMedx Group Inc – Key Employees 21
MiMedx Group Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Oct 26, 2017: MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance 23
Oct 10, 2017: MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent 26
Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance 28
Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 31
Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017 32
Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance 34
Feb 23, 2017: MiMedx Announces 2016 Record Results 35
Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance 37
Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90% 39
Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results 41
Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance 44
Jul 26, 2016: MiMedx Announces Second Quarter 2016 Results 45
Jul 11, 2016: MiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range 48
Apr 25, 2016: MiMedx Announces First Quarter 2016 Results 49
Apr 10, 2016: MiMedx Announces First Quarter of 2016 Revenue Results 51
Feb 23, 2016: MiMedx Announces 2015 Record Results 52
Corporate Communications 54
Oct 03, 2017: Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development 54
Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors 55
Jul 07, 2016: MiMedx Adds New Executive 56
Legal and Regulatory 57
Nov 01, 2017: MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions 57
Oct 04, 2017: MiMedx Files Lawsuit Related To Short Seller Attacks 58
Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 59
Sep 21, 2017: MiMedx Files Lawsuit Against The Capitol Forum 60
Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 61
Jun 21, 2016: MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims 62
May 17, 2016: MiMedx Files Lawsuit Against Osiris For False And Misleading Representations 63
Jan 06, 2016: MiMedx Receives Certificate From FDA Allowing The Export Of MiMedx Allografts 64
Government and Public Interest 65
Jun 15, 2017: Scientific And Clinical Review Confirms Potential Of MiMedx dHACM Allografts For Regenerative Applications In Orthopedics 65
Sep 15, 2016: MiMedx Urges FDA To Reconsider Draft Guidances During Hearing 67
Product News 69
Oct 18, 2017: New Clinical Evidence And A Landmark VLU Study To Be Presented At SAWC Fall Meeting 69
Apr 05, 2017: The Use Of MiMedx Allografts From The Company’s Multiple Product Families To Be Presented At SAWC Conference 71
Feb 07, 2017: Benefits Of MiMedx dHACM Allograft Chronicled In Multiple Articles In February 2017 Supplement Edition Of Annals of Plastic Surgery 72
Jan 24, 2017: Scientific Study Confirms MiMedx dHACM Allograft Promotes Cardiac Repair Following Myocardial Infarction 74
Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published 75
Oct 06, 2016: Advances In Regenerative Medicine With MiMedx EpiFix And AmnioFix To Be Presented At SAWC Fall Meeting 76
Sep 12, 2016: Scientific Study Confirms How MiMedx dHACM Allografts Effectively Promote Wound Repair 78
Other Significant Developments 80
Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed $80 Million Despite Hurricane Irma 80
Aug 09, 2017: MiMedx Hits Milestone of One Million Allografts Distributed 81
Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 82
Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance 83
Appendix 84
Methodology 84
About GlobalData 84
Contact Us 84
Disclaimer 84
MiMedx Group Inc, Medical Equipment, Key Facts, 2016 2
MiMedx Group Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
MiMedx Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
MiMedx Group Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
MiMedx Group Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
MiMedx Group Inc, Deals By Market, 2011 to YTD 2017 9
MiMedx Group Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MiMedx Enters Into Distribution Agreement With Medtronic And SpinalGraft Technologies 11
MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 12
MiMedx Completes Public Offering Of Shares For US$39 Million 13
MiMedx Group Completes Private Placement Of Shares For US$5 Million Upon Exercise Of Warrants 15
MiMedx Group Completes Private Placement Of US$6.6 Million 16
MiMedx Sells its Stability Biologics 17
MiMedx Acquires Stability Biologics 18
MiMedx Completes Acquisition Of Surgical Biologics 19
MiMedx Group Inc, Key Competitors 20
MiMedx Group Inc, Key Employees 21
MiMedx Group Inc, Subsidiaries 22